(TheNewswire)
Vancouver, British Columbia - TheNewswire - March 10, 202 2 - Blackhawk Growth Corp.(CSE:BLR ) (CNSX:BLR.CN) (OTC: BLRZF) ( Frankfurt:0JJ) (the “ Company ” or“ Blackhawk ”) is pleased to announce that its 100% owned subsidiary, MindBio Therapeutics Pty Ltd. (“MindBio”),has invested NZ$2,300,000 at a world class Australasian University toadvance its psychedelics microdosing clinical trials.
MindBio is investing in world-class facilities to fasttrack its microdosing clinical trials. MindBio’s Phase 1 clinicaltrial microdosing LSD (Lysergic Acid Diethylamide) to 80 patients athome is due for completion shortly. Two continuation studies willfollow from the NZ$2,300,000 investment including a Phase 2 clinicaltrial microdosing LSD in patients with major depressive disorder and aPhase 2 clinical trial microdosing LSD in late-stage cancer patientsstarting this year.
These clinical trials have also received governmentgrants amounting to NZ$800,000 in funding to date to support thisimportant clinical research into these emerging treatments.
This funding helps to accelerate intellectual propertydevelopment in psychedelic microdosing, associated technology andimportant clinical trial work for determining safety and efficacyacross different patient groups.
“MindBio is leading the charge on clinical trials ofmicrodosing psychedelics,” says Frederick Pels, CEO of BlackhawkGrowth. “With our Phase 1 clinical trial near completion in additionto substantial progress on our two Phase 2 clinical trials, it putsMindBio ahead of many of its peers in the development of intellectualproperty that one day may lead to helping patients with mental healthconditions.”
About Blackhawk Growth
Blackhawk is an investment holding company looking tocreate substantial value for its shareholders through the acquisitionand development of high growth companies. It has focused itsinvestments in the health, cannabis and cannabidiol industries in bothCanada and the United States. Its portfolio of companies includes SacPharma, LeichtMind Clinics, Noble Hemp, Spaced Food, NuWave Foods,MindBio Therapeutics, Digital Mind Therapeutics as well as an equityposition in Gaia Grow Corp. (CSE:GAIA).
The Company diligently posts updates through videosfrom the official company YouTube channel
Please join the conversation on our Blackhawk groupsupporter’s telegram group at https://t.me/Blackhawkgrowthcorp and visit us online at https://www.blackhawkgrowth.com .
For further information please contact:
Frederick Pels, Chief ExecutiveOfficer
(403)-991-7737
fred@ blackhawkgrowth.com
Cautionary NoteRegarding Forward-Looking Statement
All statements in this pressrelease, other than statements of historical fact, are “forward-looking information”with respect to the Company within the meaning of applicablesecurities laws, including with respect to transaction and futureoperations of MindBio Therapeutics Pty Ltd. The Company providesforward-looking statements for the purpose of conveying informationabout current expectations and plans relating to the future andreaders are cautioned that such statements may not be appropriate forother purposes. By its nature, this information is subject to inherentrisks and uncertainties that may be general or specific and which giverise to the possibility that expectations, forecasts, predictions,projections or conclusions will not prove to be accurate, thatassumptions may not be correct and that objectives, strategic goalsand priorities will not be achieved. These risks and uncertaintiesinclude but are not limited those identified and reported in theCompany’s public filings under the Company’s SEDAR profile atwww.sedar.com. Although the Company has attempted to identifyimportant factors that could cause actual actions, events or resultsto differ materially from those described in forward-lookinginformation, there may be other factors that cause actions, events orresults not to be as anticipated, estimated or intended. There can beno assurance that such information will prove to be accurate as actualresults and future events could differ materially from thoseanticipated in such statements. The Company disclaims any intention orobligation to update or revise any forward-looking information,whether as a result of new information, future events or otherwiseunless required by law.
Copyright (c) 2022 TheNewswire - All rights reserved.